Fingerprint
Dive into the research topics of 'Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: A report from the children's oncology group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically